A phase III , randomized, double-blind, double-dummy multicenter study to evaluate the efficacy and safety of 775 mg APC-111 [amoxicillin] MP tablet QD for 7 days vs penicillin VK [phenoxymethylpenicillin potassium] 250mg QID for 10 days in patients with Streptococcus pyogenes
Latest Information Update: 30 Sep 2005
At a glance
- Drugs Amoxicillin (Primary) ; Phenoxymethylpenicillin potassium
- Indications Pharyngitis; Streptococcal infections; Tonsillitis
- Focus Therapeutic Use
- 30 Sep 2005 New trial record.